13F-HR filed by Madison Avenue Partners, LP
Madison Avenue Partners, LP filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-16, with 19 holding rows worth $708,272,865.
- Accession
- 0001801265-24-000004
- Filer
- CIK 1801265
- Filed
- 2024-02-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 19 entries on the cover page, a total value of $708,272,865 stated on the cover page (in dollars after the unit check, H1), rows summing to $708,272,865 with VALUE read as dollars as filed, 13F file number 028-20035. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SHARKNINJA INC COM SHS | G8068L108 | Stock | 3,681,914 | $188,403,539 | dollars as filed | |
| GRAHAM HLDGS CO COM CL B | 384637104 | Stock | 209,401 | $145,851,985 | dollars as filed | |
| THERAVANCE BIOPHARMA INC | G8807B106 | COM | 7,012,226 | $78,817,420 | dollars as filed | |
| STAGWELL INC | 85256A109 | COM CL A | 7,147,662 | $47,388,999 | dollars as filed | |
| INTEGRA LIFESCIENCES HLDGS C | 457985208 | COM NEW | 1,042,156 | $45,385,894 | dollars as filed | |
| G III APPAREL GROUP LTD | 36237H101 | COM | 1,323,110 | $44,959,278 | dollars as filed | |
| HESS CORP | 42809H107 | COM | 300,270 | $43,286,923 | dollars as filed | |
| VESTIS CORPORATION | 29430C102 | COM SHS | 1,346,980 | $28,475,157 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 417,427 | $24,523,836 | dollars as filed | |
| ORION PROPERTIES INC COM | 68629Y103 | REIT | 2,989,565 | $17,100,312 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 3,648,509 | $11,748,199 | dollars as filed | |
| FRANKLIN STR PPTYS CORP | 35471R106 | COM | 3,291,443 | $8,426,094 | dollars as filed | |
| 2SEVENTY BIO INC COMMON STOCK | 901384107 | Stock | 1,754,788 | $7,492,945 | dollars as filed | |
| Merrimack Pharmaceuticals Inc | 590328209 | Common / Ordinary Stock | 553,085 | $7,416,870 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 5,054,472 | $4,612,206 | dollars as filed | |
| THE CENTRAL AND EASTERN EU I | 153436100 | COM | 273,957 | $2,671,081 | dollars as filed | |
| Indivior PLC | G4766E116 | Common Stock | 72,255 | $1,103,334 | dollars as filed | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 582,603 | $401,647 | dollars as filed | |
| SAFEGUARD SCIENTIFICS INC | 786449207 | COMMON STOCK | 264,049 | $207,146 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001801265-24-000004 | this filing | 2024-02-16 | acceptance time not in the bulk data set |